Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 16, 2021 10:18PM
|
Re: Response & what I will attempt...
|
2
|
Zenith Epigenetics
|
Aug 15, 2020 08:47AM
|
Re: No news, did you expect a change
|
2
|
Resverlogix Corp.
|
Sep 23, 2022 08:21AM
|
Re: ...is anybody out there at the AGM...?
|
2
|
Resverlogix Corp.
|
Oct 01, 2015 04:04PM
|
Re: 3600 patient years
|
2
|
Resverlogix Corp.
|
Feb 20, 2018 10:45AM
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 10, 2019 10:36AM
|
Re: Hopefully the bleeding has stopped....
|
2
|
Resverlogix Corp.
|
Dec 01, 2017 07:57PM
|
Re: Just got word....
|
2
|
Resverlogix Corp.
|
May 31, 2019 08:34AM
|
Re: Added a few more to the pile...
|
2
|
Resverlogix Corp.
|
Nov 08, 2017 08:13PM
|
Re: Under the radar....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 17, 2020 10:08AM
|
Re: AGM Presentation
|
2
|
Resverlogix Corp.
|
Dec 12, 2017 08:03PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
2
|
Zenith Epigenetics
|
Feb 03, 2019 07:35AM
|
Re: Deal Closing?
|
2
|
Resverlogix Corp.
|
May 29, 2019 10:43AM
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 17, 2021 08:10AM
|
Re: Quote from a January 19, 2021 review
|
2
|
Resverlogix Corp.
|
Jan 21, 2021 07:37AM
|
Re: The investing worlds' assessment on RVX!
|
2
|
Resverlogix Corp.
|
Feb 24, 2021 07:49AM
|
Re: Precedence in Gene Therapy Pricing
|
2
|
Resverlogix Corp.
|
Jan 03, 2018 03:50PM
|
Re: How come?
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 25, 2020 01:13PM
|
Re: ZHCLF trading
|
2
|
Zenith Epigenetics
|
Feb 07, 2021 08:15AM
|
Re: Don's latest presentation
|
2
|
Resverlogix Corp.
|
Sep 22, 2020 06:57AM
|